Literature DB >> 26072317

Tocilizumab for intestinal amyloidosis complicated by multi-centric Castleman's disease.

Tadahiko Tamura1, Shinobu Tamura2, Hironori Tanaka3, Yuko Ohagi1, Fumitaka Taniguchi4, Hirofumi Yamanishi4, Toshihisa Kohara4, Ritsuko Kimura4, Toshio Kurihara5, Takashi Ozaki6, Yoshio Nakano1, Tokuzo Fujimoto1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26072317     DOI: 10.1016/j.clinre.2015.05.003

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


× No keyword cloud information.
  1 in total

Review 1.  AA amyloidosis associated with Castleman disease: A case report and review of the literature.

Authors:  Luca Bernabei; Adam Waxman; Gabriel Caponetti; David C Fajgenbaum; Brendan M Weiss
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.